Modulation of interleukin-1 receptor expression by transforming growth factor-beta in cultured rabbit articular

Related Experiment Video

Updated: Aug 8, 2026

Creation of a Knee Joint-on-a-Chip for Modeling Joint Diseases and Testing Drugs
12:44

Creation of a Knee Joint-on-a-Chip for Modeling Joint Diseases and Testing Drugs

Published on: January 27, 2023

S Pronost1, N Segond, M Macro

  • 1Laboratoire de Biochimie du Tissu Conjonctif, CJF INSERM 91-06, Faculté de Médecine, Caen, France.

Osteoarthritis and Cartilage
|September 1, 1995
PubMed

Insights

Transforming growth factor-beta 1 (TGF-β1) temporarily increases Interleukin-1 receptor type I (IL-1RI) expression in rabbit chondrocytes, then down-regulates it. This suggests TGF-β1

Area of Science:

  • Cell Biology
  • Immunology
  • Biochemistry

Background:

  • Interleukin-1 (IL-1) is a key mediator of inflammation and cartilage degradation in joints.
  • Interleukin-1 receptor type I (IL-1RI) mediates the biological effects of IL-1.
  • Transforming growth factor-beta 1 (TGF-β1) is known to have chondroprotective effects, but its precise interaction with IL-1 signaling in chondrocytes is not fully understood.

Purpose of the Study:

  • To investigate the effect of TGF-β1 on IL-1RI expression in cultured rabbit articular chondrocytes (RAC).
  • To explore the functional consequences of TGF-β1's influence on IL-1RI expression on IL-1 receptor bioactivity.

Main Methods:

  • Cultured rabbit articular chondrocytes (RAC) were treated with TGF-β1.
  • Interleukin-1 receptor type I (IL-1RI) gene expression was analyzed using reverse transcription-polymerase chain reaction (RT-PCR).
  • Receptor binding assays using [125I]-IL-1 alpha were performed to assess IL-1 receptor bioactivity.

Main Results:

  • TGF-β1 transiently increased IL-1RI mRNA levels at 1 hour of incubation.
  • TGF-β1 significantly decreased IL-1RI expression at 48 and 72 hours, with no effect at 24 hours.
  • TGF-β1 reduced IL-1 receptor bioactivity at all tested time points.

Conclusions:

  • TGF-β1 down-regulates IL-1RI expression in rabbit articular chondrocytes.
  • This down-regulation may explain TGF-β1's ability to antagonize IL-1 effects.
  • TGF-β1 may play a role in articular cartilage repair by modulating IL-1 signaling.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...